Literature DB >> 1321600

Direct in vivo gene introduction into rat kidney.

N Tomita1, J Higaki, R Morishita, K Kato, H Mikami, Y Kaneda, T Ogihara.   

Abstract

We established a simple and highly efficient method for in vivo gene transfer using HVJ (Sendai virus) and liposomes. Plasmid DNA and high mobility group 1 (HMG1) protein were co-encapsulated in liposomes by agitation and sonication and were co-introduced into cells by HVJ-mediated membrane fusion. pACT SVT DNA, as a reporter gene, was introduced into the kidney of intact rats through a cannula in the renal artery, and SV40 large T antigen was detected by enzyme immunohistochemistry in glomerular cells 4 days after its introduction. This newly developed kidney-directed gene transfer method should be useful not only in basic research but also in potential gene therapeutics of renal diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321600     DOI: 10.1016/s0006-291x(05)80784-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

2.  Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus.

Authors:  M Kitamura
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 3.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

Review 4.  Gene therapy targeting kidney diseases: routes and vehicles.

Authors:  Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

5.  Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus (hemagglutinating virus of Japan).

Authors:  Kuniaki Nakanishi; Maki Uenoyama; Naruya Tomita; Ryuichi Morishita; Yasufumi Kaneda; Toshio Ogihara; Kunio Matsumoto; Toshikazu Nakamura; Akie Maruta; Shigeo Matsuyama; Toshiaki Kawai; Takashi Aurues; Takuya Hayashi; Tomosumi Ikeda
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 6.  Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.

Authors:  Harini Bagavant; Kambiz Kalantarinia; Yogesh Scindia; Umesh Deshmukh
Journal:  Am J Kidney Dis       Date:  2011-01-15       Impact factor: 8.860

7.  BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth.

Authors:  T Kaisho; J Ishikawa; K Oritani; J Inazawa; H Tomizawa; O Muraoka; T Ochi; T Hirano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Genetic engineering of vein grafts resistant to atherosclerosis.

Authors:  M J Mann; G H Gibbons; R S Kernoff; F P Diet; P S Tsao; J P Cooke; Y Kaneda; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Authors:  R Morishita; G H Gibbons; K E Ellison; M Nakajima; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 10.  Gene therapy for renal disorders: what are the benefits for the elderly?

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.